diabetic retinopathy

The US FDA has approved Genetech’s Lucentis (ranibizumab injection) 0.3 mg prefilled syringe as a new administration method for the treatment of all forms of diabetic retinopathy (DR) in patients with diabetic macular oedema Read more


A supplement that assists in protecting the eye from diabetic retinopathy is being unveiled by Philip Chapper & Company at Expopharm 2017, currently taking place in Düsseldorf, Germany. Read more

Technology 1 Comments